Phase 3 Brain Cancer Trial, Recruiting NCT06330337 Sponsor: The Third Affiliated hospital of Zhejiang Chinese Medical University Condition: Brain Cancer
Back to Brain Cancer

Phase 3 Brain Cancer Trial, Recruiting

NCT06330337
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a high-grade brain tumour (confirmed by biopsy), have already had surgery followed by standard radiation and chemotherapy, and scans show the tumour has come back.
  • You are between 18 and 70 years old (any gender).
  • If you are taking the steroid medication dexamethasone for brain swelling, your dose must be low and stable (under 6 mg per day) in the week before joining — or reducing to that level; if you take it for another reason, you may still be eligible.
  • You are reasonably well and able to carry out daily activities (your doctor would assess this using a standard performance scale).
  • You are considered suitable for acupuncture, have no serious complications that would prevent it, and are willing to attend acupuncture sessions regularly.
  • You are fully alert, can feel and recognise pain, and are able to have a basic conversation.
  • You are willing to take part and have signed a consent form agreeing to join the study.

Who may not be able to join:

  • You have epileptic seizures that are not well controlled.
  • You have more than mild nerve damage in your hands or feet (confirm with trial site).
  • You are currently in another clinical trial, or finished one less than 3 months ago.
  • You have previously been treated with paclitaxel or similar chemotherapy or biological drugs, or you have had an allergic reaction to these types of medicines.
  • Your heart, liver, kidneys, or blood are not functioning well enough — the trial requires recent blood test results (within 14 days before starting) to meet specific minimum levels (confirm exact values with trial site).
  • You are pregnant or breastfeeding.
  • You have a significant cognitive impairment such as dementia from birth, or a history of misusing alcohol, drugs, or psychiatric medications.
  • You have previously fainted from needles, or you have an infection at a site where acupuncture needles would be placed.
  • You have metal implants or other conductive objects inside your body (confirm with trial site).
  • You are unable to have an MRI scan with contrast dye.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +86-13858028101

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall survival(OS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov